Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia
β Scribed by A. U. Ural; A. Kubar; F. Avcu; H. B. Tastan; M. Safali; O. Nevruz; T. Cetin
- Book ID
- 108694272
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 579 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0307-6938
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Cutaneous presentation of B-cell chronic lymphocytic leukaemia (B-CLL) is uncommon, and the influence of skin changes on B-CLL prognosis is unclear. We report a patient with B-CLL Rai II, with multiple nodular skin infiltrations on the trunk, upper arms and thighs as well as constitutional symptoms,
Fludarabine is used widely for the treatment of chronic lymphocytic leukaemia, but not as yet implicated in the emergence of hepatitis B surface antigen (HBsAg) variants following hepatitis B virus (HBV) reactivation. Such a variant was detected in a 78-year-old female who was HBsAg(-)/anti-HBc(+)/a
lymphocytic leukemia. Besides establishing the demographic characteristics of 322 CLL cases studied, CD38 and ZAP7o was investigated in 58 vs. 64% of the cases while in 57% of the CLL cases FISH analysis for +12,13q ,11q and 17p was possible. Results: (1) The frequency of FISH detected aberrations i